What is ELISA? (Enzyme-linked Immunosorbent Assay)

Enzyme-linked Immunosorbent Assay (shortened as ELISA) is used to identify peptides, proteins, antibodies and hormones. Also, called as enzyme immunoassay (EIA), ELISA finds use in the fields of biotechnology and medicine as a diagnostic tool. Mainly, antibodies and color changes are used to identify target substances. Also, ELISAs are useful in measuring antigen and antibody concentration.

Development and Brief History

Before the advent of ELISA, radioimmunoassay employing radioactively-labelled antigens and antibodies were used. Radioactivity served as the reporter signal indicating specific antigen or antibody. As radioimmunoassay posed significant health risks to researchers, alternatives were sought.

In 1960s, Enzyme linking process was developed by two different teams spearheaded by Stratis Avrameas and G. B. Pierce. In the same period, immunosorbent preparation technique was published by Wide and Jerker Porath. Independent research papers published in 1971 by Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in the Netherlands produced the knowledge that go into making ELISA.

The conventional ELISA involves usage of chromogenic reporters and substrates to produce color changes to indicate the presence of specific antigen or an analyte. Newer Assay techniques make use of fluorogenic, electrochemiluminescent, and quantitative PCR reporters to create quantifiable signals. The advantage of using advanced reporters help in measuring multiple analytes in a single or cycle of assays (Multiplexing) and higher sensitivities (specificity and sensitivity)

Technically, newer assays use reporters that are not enzymes in most cases, nonetheless the underlying principles of the assays are similar. Therefore, these assays are grouped as ELISAs.

ELISA Principle

ELISA works by coupling antibody or antigen to assay enzyme. The assay combines the specificity of antibody and sensitivity of assay enzymes to primarily detect antigens through assay antibody or antibodies through assay antigens. The sensitivity and precision of the assay is enhanced by coating the plate with high-affinity antibodies.

Basics of ELISA

ELISA (enzyme-linked immunosorbent assay) was devised as an alternate approach for radioimmunoassays during the early 1970s. This is a plate-based assay intended towards recognition and quantification of proteins, antigens, peptides, antibodies and hormones. The elementary enzyme-linked immunosorbent assay (ELISA), or enzyme immunoassay (EIA), is different from the other available antibody-based techniques in a way that in a polystyrene (96 or 384) multi-well plate (which is considered good for protein binding) the binding to solid surface sequentially results in the identification of specific reactions excluding the non-specific ones. This results in the generation of quantitative results. It is this obligatory binding and immobilization of components that is unique to this process making ELISAs exclusive and easy to implement. The participating reactants in ELISA that is immobilized to the surface of the microplate enable differentiation of the reactants that have bonded out of the non-bound unspecific reactants throughout the analysis. In an ELISA, the antigen or antibody is bound onto a solid surface usually onto a micro-well plate and thereafter it is interacted with a counterpart antigen/ antibody. The counterpart antigen/ antibody is connected to a reporter molecule like an enzyme or alternatively can be detected by a secondary antibody that is in turn linked via conjugation to an enzyme. The detection of the assay is carried out by evaluating the enzyme activity of the conjugate which is implemented by incubation with a suitable substrate for the enzyme resulting in a generation of a quantifiable product. Generally, the ELISA technique results in a colored end product which absorbs at a particular wavelength and can be correlated to the quantity of analyte in question present in the sample. An extremely specific antibody-antigen interaction is the utmost critical component of the entire process. This capability of the process to wash away non-specific unbound reactants makes the ELISA technique an influential and reliable means for gauging precise information on the analytes even when present within a crude and impurified sample.

ELISA has been implemented in diagnostics as well as for quality-control programmes throughout a number of industries. They are rapid and easy to carry out, and because they are premeditated to swiftly carry out high throughput screening and multiplexing, they have made a breakthrough in the widespread assessment of various investigations as well as diagnostic assays.

ELISAs have retained their position in extensive use either in their original form or in extended forms with certain amendments allowing for more than two analytes in each well, extremely sensitive data, and straightforward output. These assays function on many similar principles as when compared other immunoassay techniques available. In the interest to make the most of it in terms of the sensitivity and accuracy of the assay, it is required that the plate is coated with great care using high-affinity antibodies. It is to be noted that, ELISA can be implemented to perform other types of specific ligand binding assays as an alternative to only immunoassays. This process necessitates the use of a ligating reagent immobilized on the solid support which in presence of a specific detection reagent can implement an enzyme-substrate reaction to generate an output signal that in turn helps in quantification.

Methods in ELISA

The process begins with coating the multi-well plate with either antigen/antibody usually taking 30 min to overnight incubation which is followed by primary antibody reaction for 2 hours after blocking. Then the application of secondary antibody is carried out with further incubation for 2 hours, thereafter substrate preparation is generally done freshly just before the reaction and finally development which takes near about 30 mins.

The components in the ELISA are immobilized which makes the process easy to perform. But as the assay requires the use of surface binding for appropriate separation, washing is carried out several times repeatedly after each step inorder to ensure removal of unbound entities. The excess fluid is to be necessarily removed during the course of the reaction in the interest to prevent the unwanted dilution of the reagents that will be added in the subsequent steps. For ensuring the desired uniformity dedicated plate washers are implemented in this process.

As ELISAs incorporate multistep reactions it can become quite complex in case of measurement of analyte concentrations in case of complicated samples such as blood as there is a presence of a significant amount of analytes that can interfere with the measurement. Herein, the role of the detection step becomes important where the signal amplification can be achieved via the use of several coatings of antibodies. A color producing substrate, like Tetramethylbenzidine (TMB), in staining.  It produces the color based on an enzymatic reaction. The substrate can be chosen based on the instrument available like in case of colorimetric reactions spectrophotometers are used and in case of a fluorometric tag fluorimeters are implemented.

Categories of ELISA

The ELISA experiment primary initiates with the step of immobilizing antigen of a given sample into the the wells of a multiwell plate. The process of immobilization can be attained via two methods which include direct adsorption to the surface of a plate or through an antibody capture probe adsorbed to the plate. The antibody probe must be highly specific towards antigen of interest. The immobilization is trailed by addition of detection antibody that results in an antigen-antibody complex. The antibody applicable for detection is usually tagged exploiting enzymes like alkaline phosphatase (AP) or horseradish peroxidase (HRP). ELISAs can be classified into following four major categories namely direct, indirect, sandwich, and competitive depending on the modifications performed to basic procedures. Sandwich ELISA is the most powerful format in ELISA assay due to its high sensitivity and robustness The substrate choice for the assay depends upon the requisite sensitivity, the type of the instrumentation required and its availability.

Direct ELISA

The detection via direct ELISA procedure is much faster as compared to other ELISA techniques due to limited steps followed. This technique allows for coating of antigen directly to wells of microtitre plate which is  followed by the addition of enzyme labelled primary antibody that detects the antigen that is complementary. The assay is beneficial as it is minimally error prone due to the implementation of a lesser number of steps requiring only a handful of reagents. There is no requisite of cross-reacting secondary antibody in this technique. But this technique poses a few disadvantages with regards to its specificity. Since specificity of antigen immobilization is low, there is an occurrence of higher background noise as compared to other ELISA techniques. This is due to the non-specific interaction of sample proteins along with target protein in a microtitre plate. The flexibility of direct ELISA is minimum since each target protein is required to be bound by enzyme labelled primary antibody. The labelling procedure for each primary antibody is laborious and time consuming which would adversely affect its immunoreactivity.   The lack of secondary antibody minimises signal amplification, that reduces the sensitivity of the assay. Therefore, the direct ELISA technique is preferred mostly to analyse the immune response towards an antigen.

Advantages   

  • Fast and minimal steps involved in the procedure.
  • Minimum precursor requirement makes it less error prone.

 Disadvantages

  • The immobilization of the antigen is not specific due to which background related issues are seen.
  • Offers less flexibility in terms of primary antibody.
  • The absence of signal amplification reduces sensitivity.

Sandwich ELISA

Sandwich ELISAs employs the usage of antibody pairs such as capture antibody and detection antibody which can be a monoclonal or polyclonal antibody. Each antibody is highly specific towards epitope of an antigen and the assay is found to be more suitable for antigens possessing two epitopes. The specificity of matched antibody pairs is very important to confirm their binding to different epitopes in obtaining precise results. As its name indicates, the capture antibody interacts with an antigen which can then be detected via both direct and indirect ELISA techniques. Since the antigen quantification is taking place between upper and lower layer of antibodies, the entire method is termed as sandwich ELISA. A sandwich ELISA applied for investigation more often demands validation as it falls under the risks of delivering false positive results. Sometimes the development of the sandwich ELISA assay takes considerable time owing to the procurement of matched pairs of antibodies that is required.

The primary step in sandwich ELISA involves coating of ELISA plate with a capture antibody. To this antibody coated plate, a sample containing antigen is added, followed by antibody detection. The detection antibody can be either enzyme labelled or enzyme unlabelled, depending on which it will be direct sandwich ELISA or indirect sandwich ELISA respectively. In indirect sandwich ELISA, a secondary enzyme-labelled antibody based detection is introduced that binds to the primary unlabelled detection antibody. Sandwich ELISA is found to be 2-5 times more sensitive when compared to direct and indirect ELISA techniques. The higher specificity of sandwich ELISA is attributed to the usage of two antibodies which detect the antigen of interest. Since the implementation of both direct and indirect methods is possible, the technique promises more flexibility in detection procedure. The analysis of a complex sample with high specificity and sensitivity is possible through this technique as it requires no prior purification of antigen.  But the technique brings few disadvantages which are to be considered. It is important to have an optimised and tested ELISA kit for specific reaction and detection. The unavailability of standardised kit would demand the optimization of antibody to avoid cross reactivity of capture antibodies with detection antibodies which is time consuming.

  • Direct Sandwich: With this type of assay an enzyme conjugated antibody is applied for detection or fluorescence moiety is used. After the incubation in presence of the immobilized antibody-antigen complex on the well of the plate, output signal detection is performed when the chromogenic substrate is applied or via exciting and collecting the emission signal of the fluorophore.
  • Indirect Sandwich: Herein the assay uses consists of either an unconjugated or biotinylated antibody for detection purpose which when bound to the antibody-antigen complex can de be distinguished by either streptavidin or anti-species antibody conjugated to an enzyme or fluorophore.

Advantages   

  • Offers high sensitivity compared to direct or indirect ELISA
  • Introduces highly specific reaction due to the involvement of two antibodies for antigen detection.
  • Both direct and indirect technique is implemented in detection.

 Disadvantages

  • Optimization in terms of antibody becomes problematic due to cross-reactivity issues.
  • For recognition of a specific epitope, only monoclonal antibodies can be applied as matched pairs.
  • To procure monoclonal antibodies it is a tedious process in case of matched pairs and are more expensive than polyclonal antibodies.

Indirect ELISA

The indirect ELISA method exhibits higher sensitivity since it employs enzyme labelled secondary antibody which interacts with a primary antibody. The technique is considered to be comparatively economical than direct ELISA due to the requirement of fewer labelled antibodies. The higher flexibility of indirect ELISA is notable since it enables enzyme labelled secondary antibody to bind with various primary antibodies. The secondary antibody is mostly polyclonal in origin with anti-species reactivity.  But the limitation to be concerned in this technique is the issue of cross reactivity of secondary antibody with a bound antigen that may create more background noise. There is a necessity of an extra step where incubation of secondary antibody is performed that leads to more time consumption. The indirect ELISA helps in quantifying the total concentration of antibody in samples.  Some of the advantages and disadvantages listed below:

Advantages

  • Offers high sensitivity and flexibility as the number of secondary antibodies can bind to a primary antibody and one type of secondary antibody can label different primary antibodies
  • It is cheaper as there is a requirement of fewer labeled antibodies.

Disadvantages

  • Higher signal to noise ratio.
  • Time consuming and extra labour required.

Competition/Inhibition ELISA

The competition/inhibition ELISA which is otherwise termed as blocking ELISA is known to be a plate/surface based assay. It is one of the most complex assays performed above all the remaining ELISA techniques. However, it is to be noted that the other ELISA types can also be modified to fit into the competitive format. The working mechanism of this technique predominantly measures and quantifies the antigen or antibody concentration in a given sample based on the supposed signal output by resultant interference. Basically, it exhibits a competitive interaction of sample antigen or antibody to labelled antibody or antigen which is in limited concentration respectively. The obtained signal output is inversely proportional to the concentration of antigen in a sample where there is an output of a weaker signal at higher concentration of antigen.

This example demonstrates primarily the coating of a known antigen on a microtitre well plate. After the completion of optimum blocking and washing procedures, unknown antigen containing samples are added. It is trailed by the addition of labelled detection antibody using suitable substrates like  3,3’,5,5’-Tetramethylbenzidine or TMB. The major step in competitive ELISA or inhibition ELISA is the process of competitive reaction between the target antigen present in the sample and antigen that is bound multiwall plates with the available primary antibody. The higher antigen concentration in the sample is denoted by a significantly lowered signal output. In contrast, antigen in the sample at a very low quantity will give rise to higher signal output. It is best applicable when the availability of antibody is reduced to one for the target antigen. It is also apt for distinguishing minor amounts of antigens that cannot be detected even by two distinct antibodies such as in the sandwich ELISA technique. In most of the cases, inhibition assays provide the sample to be tested the opportunity for preferential binding over other interfering components as it is added before them.  In case of  competitive assays, the target sample is first incubated with the other component before the reaction proceeds further.

 Advantages

  • Negligible sample processing is required and can be applicable to crude samples
  • Less sensitive to experimental errors.
  • Good reproducibility and flexibility.

Disadvantages

  • Basic ELISA limitations apply.

Options available for output detection

The detection of the output signal in ELISAs is dependent on an enzymatic probe which produces a measureable signal proportional directly to the presence/amount of an analyte bound to a specific antibody. A variety of enzyme-substrate reactions are usually applied for ELISA detection and the ultimate output is measured with a microplate reader either in fluorescence or spectrophotometric mode depending on the type of substrate in action.

Direct ELISA detection

The most commonly used ELISA detection strategy is that the labelling of the antibodies is carried out directly with alkaline phosphatase (AP) or HRP which produces a colorimetric output signal detected via spectrophotometer. These fall under the category of chromogenic assays which results in a product absorbing in the visible range producing a visible color where repeated washing is mandatory in removing interfering analytes. The antibody which is  enzyme labelled produces a colored product via catalysis in presence of an appropriate substrate. Since the enzyme is highly efficient in conversion, the reaction can be proportionately sensitive in nature.

Enzymes

Alkaline phosphatase derived from Escherichia coli  has an optimum activity at pH 8.0 whereas the AP mined from calf intestines has optimal pH at 9.6. As a result, there are fair chances of a low enzyme to antibody conjugation ratio along with the steric hindrance concerns associated with the higher molecular weight of alkaline phosphatase in case of closely packed antigen-antibody conjugates ultimately resulting in lower activity. However, stable nature of  alkaline phosphatase renders it applicable with a wide range of substrate molecules. A product insoluble in nature is generated by  is BCIP/NBT (5-bromo- 4-chloro-3-indolyl-phosphate/nitroblue tetrazolium) and it is accepted as the utmost effective substrate in case of immunoblots as a result of its stability in presence of light. In case of production of a soluble reaction product p-NPP (p-nitrophenylphosphate) substrate is utilized that generates a product yellow in color absorbing at 405 to 410 nm. The sensitivity can be increased in this case by allowing a longer development time. This reaction normally takes half an hour to complete and can be stopped using 1N NaOH or chelating agents. However, the reaction takes extended periods of time to execute it is not recommended for kinetic analysis.  One of the major disadvantages that hinder the use of alkaline phosphatase is that it is deactivated at acidic pH (< 4.5) as well as in presence of chelating agents. There is a requirement of specific buffers, wash solutions for the assay. Nevertheless, it offers a  low signal to noise ratio with high sensitivity.

 Hydrogen Peroxidase typically binds to an antibody in a 4:1 ratio. It contains a heme group that absorbs at 403 nm in combination with an apoenzyme (enzyme) with an absorption at 275nm. The problem associated with steric hindrance is negligible in this case as a result of its low molecular size. Peroxidase is inexpensive as well as a number of substrates producing soluble otherwise insoluble products are abundantly obtainable for peroxidase.  One of the major challenges associated with the use of peroxidase is its sensitivity to most of the preservatives present in buffer solutions that renders it inactive. Also, some of the metals present biological samples may interfere with peroxidase activity. However, by use of sterilised buffers and reagent grade solvents these problems can be mitigated to an extent. The utmost commonly applied substrates for peroxidase producing insoluble product are DAB (3,3′,4,4′ diaminobenzidine), TMB (3,3′,5,5′ tetramethylbenzidine), and  the substrates giving rise to soluble products are TMB (dual function substrate), ABTS (2,2′-azino-di [3-ethylbenzthiazoline] sulfonate) and OPD (o-phenylenediamine). Out of these TMB that produces a blue product with an optical absorbance at 650 nm is a highly sensitive substrate and has a fast rate of reaction as a result of which it can be applied for kinetic studies. ABTS although less sensitive than TMB, produces a blue-green soluble product with an absorption at 405 to 410 nm and is available as a multipurpose substrate offering a wide working range. The rate of reaction in this case is suitable for end point studies. In a nutshell, the HRP based system is widely used due to its ease of implementation and economic feasibility even though its slightly less sensitive than AP.

 Fluorescence labelled antibodies when applied in detection of ELISA it is termed as fluorescence-linked immunosorbent assay (FLISA). Fluorescent based  immunoassays involved an enzyme substrate reaction that  produces a fluorescent product. The relative fluorescence intensity and the amount of analyte is proportional in nature. As  compared to the colorimetric ELISA, the fluorescent assays are background free and hence more sensitive additionally also have a wide dynamic range.  These are various formats similar to that of standard ELISA. The are various types of fluorescence or  luminescence that are applied in immunoassays are bioluminescence, chemiluminescence, photoluminescence that vary in terms of the process by which the excited state is gained. Fluorescence or  luminescence is supposed to be the  most sensitive method of detection available because of its signal amplification properties. The enzymes mostly applied for fluorescence based immunoassays are also AP and HRP but with different substrates. As discussed above HRP can be applied in wide range of applications with an intense, stable signal in both bioluminescent or chemiluminescent formats. The appropriate substrates for fluorescence based assays involving  peroxidase are luciferin, polyphenols, luminal (3-Aminophthalhydrazide), and acridine esters. In this luciferin is dependent on bioluminescence mechanism. Out of all, the widely accepted substrate is luminal and its derivatives applied in clinical diagnostics owing to its enhanced luminescence characteristics . The others are chemiluminescent based substrates that involve polyphenols demonstrating an outstanding signal to noise ratio and exceptional photostability.  However, control of optimum pH is utmost important in fluorescence based detection.  Its advantages include ultra-high sensitivity, wide dynamic range, low background.

Indirect ELISA detection

In this case, the antibodies are combined with biotin successively followed  by an enzyme streptavidin conjugation stage. Unlabelled primary antibodies can also be applied consecutively to enzyme-conjugated or biotinylated secondary antibodies. In case  the biotinylation of the  secondary antibody is carried out then a further stage for detection purpose such as a tertiary step is required. Herein, the after addition of a suitable substrate the treatment with streptavidin-enzyme conjugate is done.

Ready to use ELISA kits

These are commercially available kits for detection applicable for specific purposes

There are two types kit that are available for most of the targets:

  • ELISA kits containing pre-coated antibody-plates, antibodies for detection, specific buffers, standards, diluents and substrates. Additionally, there are kits known as Instant ELISA kits that are available with pre-coated plates including only the capture antibody which in presence of the sample contain the essential constituents like the capture antibody and lyophilized detection antibody, streptavidin-HRP, and sample diluent. In addition, the strip wells that contain the standard for calibration are made available separately.
  • The second type of kit is known as Antibody pair kits that are made up of individual matched antibodies and standard devoid of plates and  reagents for  detection.

These kits are all are ready to use and are  offered in several  formats as well as quantitative, semi-quantitative, indirect or competitive. They are also known to give  reproducible results within  90 minutes. Some kits even simplify the whole procedure by implementing protocols like one incubation – one wash, without compromising the performance of the assay in question . Also, they implement a standardised protocol  for multiple purposes for ease of application.

These kits are all are ready to use and are  offered in several  formats as well like  quantitative, semi-quantitative, indirect or competitive. They are also known to give  reproducible results within  90 minutes. Some kits even simplify the whole procedure by implementing protocols like one incubation – one wash, without compromising the performance of the  assay in question . Also, they implement a standardised protocol  for multiple purposes for ease of application.

 Result analysis in ELISA

The ultimate step of the  ELISA process includes the calculation of results which is required to be paid special attention as the success of the whole process relies on it. The ELISA assay produces data output of three different types as given below:

  1. Quantitative: Data can be inferred via comparison with a standard curve which is generally a serially diluted sample of the purified known concentration of antigen. This requirement is necessary in order to accurately compute the concentrations of antigen in a given unknown sample.
  2. Qualitative: Sometimes it is not mandatory to analyse the exact concentration of analyte present in a sample instead only information about its presence or absence is mandatory in arriving at conclusions. ELISAs can be applied to attain such an analysis where it indicates whether a  particular antigen is present or absent in a sample when compared to a control well without any antigen which can sometimes also be a dissimilar antigen also.
  3. Semi-Quantitative: In this format, ELISAs are compared with the relative amounts of antigen in the samples. This is so because the strength of the signal obtained will vary proportionately with antigen concentration.

The data output in ELISA is characteristically plotted with respect to optical density or fluorescence/luminescence vs concentration producing a sigmoidal curve. For generation of a standard curve the amount of antigen in a known sample are exploited. Thereafter, the linear portion of the standard curve obtained in the previous step  is exploited to quantify the amount of unknown antigen present in the sample. Actually,  the  relatively extended linear portion of the standard curve  gives reproducible and accurate results in ELISA. The unknown concentration can be calculated by using plotted graph or by using  software for curve fitting.

Calibration curve models

When there is a requirement of a quantitative result, the easiest way to advance is by taking the  triplicate average of the standard’s data and from that value deduction of the blank control sample  value is carried out. In the next step the standard curve is plotted and the line of best fit is ascertained  inorder to determine sample concentrations. Whatever dilution is required is to be realised at this point for adjustments. In the case where the optical density or the fluorescence signal of the  sample extending the upper limit of the standard curve then the samples should be further diluted before going on with the process in order to ensure a precise result which is later on compensated by multiplying the dilution factor. Data plots can also be obtained by means of log/log, semi-log,  log/logit and its derivatives. The use of  software based and machine learning solutions renders it practical towards consideration of more sophisticated graphs. Linear regression can be applied via software module which contributes towards assessment of other additional important parameters like the overall goodness of fit. For that to happen the R2 values >0.99 should be applicable in the  portion of the curve where the concentration has a relationship with the values. More amount of accuracy can be further inculcated using more number of concentration in making the  standard curve. One of the features of the linear plot is that the data points are compressed at lower concentrations of the standard curve thereby allowing the area to be most likely to attain the essential R2 value. If this compression implies to be counteracted a semi-log chart can be applied where in the log of the concentration value  is plotted against the values. This process yields an S-shaped data curve which allocates more number of data points making it an adaptable sigmoidal pattern. The log of concentration vs the log of data plot  produces a data curve with a more linear portion. At concentration range low to medium the standard curve is usually linear with this type and at higher concentrations alone it inclines to slope off. The log/logit and its derivatives and other logistic models are further sophisticated that demands extra complex calculations and other estimations. With these calibration curve models an  better presentation can be provided.  Instead, back-fitting of the standard curve data can also be carried out in certain cases.

Coefficient of variation calculation

The coefficient variation or CV  is the ratio of the standard deviation σ to the mean µ:

Cvσ
µ

It specifies any irregularities and inaccuracies in the results. A Large variance gives an indication of inaccuracy and error.

Spike recovery

This  regulates the interference of other constituents in a sample that can cause hindrance to the detection process of the antigen by the antibody. Many proteins, chelating agents, metal ions contained biological samples may affect the binding of the antibody to the specific antigen thereby increasing the background noise, that may result in a false negative. To alleviate this known concentration of protein are spiked into both the sample matrix and a standard diluent. Quantification is carried out for the spiked protein in both the cases and the results are compared. In case the results from both are indistinguishable  then the sample matrix is regarded as suitable for analysis. If the results are different then it can be concluded that the constituents of sample matrix can interfere with the detection process.

ELISA Sensitivity

ELISAs are regarded as one of the most sensitive immunoassay platforms presently available. The characteristic detection range for an ELISA lies between 0.1 to 1 femtomole or 0.01 nanogram to 0.1 nanogram, wherein the sensitivity relies upon the specific physiognomies of the antibody-antigen interaction involved in the assay. Moreover, some of the substrates available which produce an improved luminescent or fluorescent signal can be applied  to increase sensitivity . As discussed  earlier, an indirect format of detection yields higher intensities of the output signal and are thereby found to be more sensitive compared to others although it can also produce higher background thereby leading to non-specific signals.

Troubleshooting

In case of no signal

  • The assay has proceeded incorrectly or the use of reagents was not appropriate. In this case, the protocol must be  reviewed and the assay must be repeated with a suitable positive control.
  • The secondary antibody used was not eligible and it is required to review and repeat the assay with the accurate secondary antibody .
  • Amount of antibody used is not sufficient and the  concentration of the primary and/or secondary antibody must be increased.
  • The reagents used for detection may be contaminated hence, the use of fresh reagents is recommended.
  • The coating of the antigen may be improper inorder to correct it coating can be carried out for an extended time and different buffers can be explored.
  • The plate reader settings can be checked for correct parameters.
  • The activity of the antibody can be lost due to repeated freeze/ thaw cycles hence, the use of fresh antibody is recommended.
  • The concentration of antibody may be low and the optimisation of correct antibody concentration is required.

In case of weak signal

  • The quantity of detection reagent needs optimisation.
  • The temperature of incubation is low and optimisation of correct temperature is required before the assay is carried out.
  • The concentration of primary and/or secondary antibody may be too high therefore reduction of concentration is required to be done.
  • The specificity of antibody towards the target antigen is not present. The application of a proper blocking buffer or a purified antibody derived by affinity chromatography is required.
  • Less number of washes, increasing the number of washes can solve the related issue.
  • Use of correct proportion of blocking reagents is recommended. Washing should be carried out thoroughly before antibody binding.

In case of high background

  • The concentration of primary and/or secondary antibody used is high. An optimisation is required.
  • The specificity of antibody towards the target antigen is not present. The application of a proper blocking buffer or a purified antibody derived by affinity chromatography is required.
  • The concentration of detection reagent is high and dilution can solve the issue.
  • Increase number of washes.
  • Use of fresh blocking reagent is recommended to avoid any contamination related problems.
  • Use of correct proportion of blocking reagents is recommended. Washing should be carried out thoroughly before antibody binding.
  • The use of stop solution is recommended to avoid overdevelopment
  • Saturation of readings may occur if the plate is left too long before measurements.
  • Interference from the bottom surface of the plate may lead to such issues thereby cleaning is recommended.
  • Substrate incubation is supposed to be carried out in dark.
  • Optimum incubation temperature should be used.
  • Uneven temperature distribution should be avoided.
  • Reagents should be mixed properly to avoid pipetting errors.
  • Washing of the wells should be carried out consistently
  • Evaporation from the wells should be avoided by placing lid.

In case of slow development

  • Solutions used may be contaminated hence the use of the fresh solution is recommended.

In case of high CV

  • Pipetting errors may occur therefore it should be ensured that the correct volume should be dispensed every time from the pipette.
  • Mixing of reagents between the wells may lead to error.
  • Cross contamination of reagents and microbial contamination of samples or reagents.
  • Temperature variations across the samples.
  • Evaporation of samples can lead to it and can be avoided by ensuring the lid is placed.

Choice of assays

The most difficult question is to answer when initiating the use of ELISAs is, which system or type of ELISA is more appropriate. To answer this following questions must be addressed.

  1. Purpose of assay
  2. Reagents present
  3. Test to be developed for research purpose or be used alone  or for use by others
  4. Test to be used in other laboratories
  5. Is a kit required?

These questions have a direct effect on the phases that might be put forward as a general rule for the development of any assay. For eg.

  1. Feasibility – proof that a test system can work
  2. Validation – Showing that a test is stable and that it is evaluated over time and different conditions
  3. Standardization – It is quality control and establishment that a test is precise and can be used by different workers in different laboratories.

Although this is simplistic approach , the recognition as to why an ELISA is being developed is essential, which is often forgotten.

 ELISA plates

Polystyrene or polyvinyl chloride flat-bottomed, 96-well plates are used in the vast majority of ELISA assays. 96-well plate comes in 8-well or 12-well strips. Alternatively a strip well plate has also been used. Other variants are 384-well and 1536-well plates. They can process more samples per plate. These are exclusively used in high throughput screening  and they require automated handling. Some enzyme substrates, such as those that produce fluorescent or chemiluminescent signals may require opaque plates for optimal results. Many manufacturers supply plates designed for ELISA and provide a standardized product. The use of a wide variety of plates from different manufacturers has been reported for a broad spectrum of biological investigations. It is impossible to recommend one product as a universally accepted plate. Ideally, flat bottomed wells are recommended in which spectrophotometric readings is employed to assess color development. However round bottomed wells can be used in which visual assessment of the ELISA is made. Such plates can be read by a spectrophotometer but are not ideal. The performance of plates should be examined for a given assay on a routein basis, as it is difficult to assume that the plates will not vary in performance. It becomes an important exercise when different batches of plates are used. The batch no usually can be obtained from the boxes in which plates are provided.

Standard polystyrene ELISA plates categorised into the low, medium and high binding type. Low binding plates capture around 100–200 ng of IgG/cm2 whereas high binding capture around 400–500 ng of IgG/cm2. It becomes imperative to use ELISA plates for ELISA experiments as these plates are designed to maintain consistency, minimizing edge effects and providing optimal optical conditions for data collection. Antigen or antibody pre-coated ELISA plates are also commercially available separately and also as part of an optimized ELISA kit with all components included.

 Antibodies and probes – monoclonal and polyclonal

The antibodies used in ELISA are generally termed as primary, secondary, capture, detection etc. The antibodies can be monoclonal, polyclonal, or a combination of both. It is important to appreciate the differences between them and how these can be used. The interaction between antibodies and their antigens is described in three ways: specificity, affinity, and avidity. Antibody binding solely to a unique epitope from a single antigen in a single species, or similar epitopes present on several molecules from a few different species is called specificity. Affinity is the binding strength of an antibody to a single epitope. Affinity determines how much antigen is bound by an antibody, how quickly binding occurs, and for how long the binding lasts. High affinity antibodies produce the greatest number of stable immune complexes and therefore provide the most sensitive detection. Hence, are the best choice for all types of immunoassay. Avidity is a more complex term that accounts for the total stability of the antibody-antigen interaction. It is based upon affinity, but is also influenced by the valency of the antibody, or total number of antigen binding sites. Thus, avidity varies with isotype and whether the antibody is intact or fragmented. There is also a contribution made by the spatial arrangement of the whole complex.

 Monoclonal antibodies

Monoclonal antibodies are specific for a single epitope i.e a small region of protein. As a result, they are helpful in reducing cross reactivity and are not generally expected to trigger non-specific signals in a given immunoassay. They are used in sets as matched pairs or in conjunction with a polyclonal antibody to enhance signal or to provide a greater chance of capturing antigen from a complex solution. Monoclonals have an inherent monospecificity toward a single epitope that allows fine detection and quantitation of small differences in antigen. A polyclonal is often used as the capture antibody to pull down as much of the antigen as possible. Then a monoclonal is used as the detecting antibody in the sandwich assay to provide improved specificity. If specificity is needed during binding of analyte capture antibody is monoclonal then once the plate is washed only analyte of interest remains then detection is usually a polyclonal.

 Polyclonal antibodies

Polyclonal antibodies are complex antibody pools containing various epitopes of a single antigen. Due to the heterogeneity of epitopes, polyclonal antibodies can be powerful tools for the thorough detection of an antigen. It is also rare that they will fail to bind due to a single blocked antibody binding site, antigen configuration change, or misfolding. Polyclonals result in higher non-specific signal as they are more likely to share one or more epitopes with closely-related proteins. One solution to reduce this problem is to use affinity purified or cross-absorbed polyclonal antibodies. Sometimes the detection method for an ELISA is switched from direct to indirect detection, and thus from a monoclonal to a polyclonal, in order to increase assay sensitivity due to higher levels of polyclonal antibody binding to the target antigen. They can be used as capture and detection antibodies. Antibodies from the same polyclonal batch can both capture the analyte and subsequently also detect it, in a biotin conjugated format. Polyclonal antibodies being poly-specific may tend to capture other structurally similar molecules that may have some small resemblance the antigen of interest. This in turn which lead to false positive results. Polyclonals can vary significantly from batch-to-batch, and must be tested and validated thoroughly.

 ELISA buffers

Several different buffers used during an ELISA are –

Coating

Blocking

Washing

Sample and antibody dilution

Buffers can be produced in house or sourced from a variety of commercial antibody and reagent suppliers.

 Coating buffers

This is the first step in ELISA where a antigen or antibody in required dilution is incubated until adsorbed to the surface of the well (generally overnight). Due to hydrophobic interactions between the amino acids side chains on the antibody or antigen and the plastic surface passive adsorption occurs. Adsorption is also dependent on few other factors such as time, temperature, pH of the coating buffer and concentration of the coating agent. Typical coating conditions involve adding 50-100 μl of coating buffer, containing antigen or antibody at a concentration of 1-10 μg/ml, and incubating overnight at 4°C or for 1-3 hours at 37°C. Alternative temperatures, times, buffers, and coating agent concentrations can be used and should be tested by experimentation. During coating, it is important to maintain a moist environment in the well to minimize evaporation; plate sealers are generally used to achieve this. For optimization of coating antigen or antibody concentration a range of concentrations of coating agent has to be tested. A higher concentrations of antibody/antigen may actually have a negative effect on coating, leading to oversaturation of the wells, which can inhibit antibody binding due to steric hindrance. When crude antigen or antibody preparations are used for coating, it is possible that the effective antigen/antibody concentration may be low and outcompeted by contaminating proteins, making the specific assay signal too low to be useful. Coating buffers stabilize the antigen or antibody which is used to coat the ELISA multiwell plate, maximizing adsorption to the plate and optimizing interactions with the detection antibody. It is imperative that no other proteins are included in the coating buffer as these will compete with the antigen for binding to the plate. The two most common coating buffers are bicarbonate buffer at pH 9.6 or PBS

 Blocking buffers

Blocking is a necessary step in ELISA to prevent the non-specific binding of detection antibodies to the multiwell plate surface itself. Proteins and detergents are two main types of blocking agents. Proteins are classified as permanent blocking agents and hence added after the capture antibody has adsorbed to the well surface. Detergents only block temporarily, meaning their blocking function disappears during washing steps. Identifying a blocking buffer is completely users choice which has two main considerations namely reducing the nonspecific binding i.e. background and desired sensitivity. Blocking agent can consist of an unrelated protein or a protein derivative that does not react with any of the antibodies used in the detection step. When a plate is fully blocked, assay sensitivity will be enhanced since additional non-specific signal will be reduced. The most commonly used blocking buffer contains 1% BSA or milk proteins dissolved in PBS. Usually 150 – 250 μl of blocking buffer is added to the well to incubate for one hour at 37°C in order to fully block the plate.

 Washing buffers

ELISA wash steps remove unbound nonspecific materials and are very important component of ELISA protocol as ELISA uses surface binding for separation. The wash buffer is generally PBS, with a small concentration of a non-ionic detergent such as Tween-20. Washing is typically repeated 3-5 times between each step in the ELISA, with 30 second incubation for each wash step to thoroughly remove unbound nonspecific material. It has been observed that more number of wash is of significance than more time of wash incubation. In the final wash step excess of wash solution must be removed to prevent the dilution of the reagents added in the subsequent stage. Simply tapping the washed plate upside down on an absorbent paper helps to remove excess liquid. It is crucial not to let the plate dry out.

 ELISA Test-Control samples

Controls are very important for performing ELISA as they help in several ways. Different controls have different functions to play. Based on the function controls are named as negative, positive and standard.

 Blank control

In an ELISA experiment blank wells are the ones where only primary antibody is excluded and other components are added. Blank wells don’t show any color. In some cases blank and negative control are same.

 Negative control

The negative control in an ELISA test means a sample known not to express the protein of interest. This helps to check for non-specific binding and false positive results. Each experiment should contain a negative control sample in order to validate the results.

 Positive control

In an ELISA test, positive control has an important role to play. A positive test for positive control indicates that the protocol is working fine. It will verify that any negative results are valid. A positive control can be an endogenous soluble sample known to contain the protein being detected. A purified protein or peptide known to contain the immunogen sequence for the antibody being used, can also be a positive control. Any tissues, cells or lysates that have been used successfully can be considered a suitable positive control.

 Standard

A sample containing a known concentration of a protein from which the standard curve can be obtained. Then this standard curve can be extrapolated in order to calculate the unknown concentration of the protein.

 ELISA Result

To get accurate result all ELISA experimental samples are processed in triplicates. Output in an ELISA experiment are mostly qualitative, however it can be quantitative and semi quantitative also. For quantifying results from ELISA a standard curve is needed.

In case of qualitative ELISA, we can get a yes or no answer which is indicative of presence or absence of a particular antigen in a sample. This interpretation is done in comparison to a blank well which doesn’t contain antigen or contains an unrelated control antigen. On the other hand for quantitative ELISA results, output data has to be interpreted in comparison to a standard curve (a serial dilution of a known, purified antigen) in order to precisely calculate the concentrations of antigen in various samples (Figure 1). In semiquantitative ELISA, the relative levels of antigen in assay samples are compared, since the intensity of signal will vary directly with antigen concentration.

Standard curve

ELISA data is typically graphed with optical density vs log concentration to produce a sigmoidal curve as shown in Figure 1. A standard curve is plotted using known concentrations of antigen and then this data is used to measure the concentration of unknown samples by comparison to the linear portion of the standard curve. This can be done directly on the graph or with curve fitting software which is typically found on ELISA plate readers.

 Calibration curve models

 For quantitative result, the reading of the blank control sample is deducted from the average  triplicate of the standards readings. With the standard readings a standard curve is plotted and the line of best fit is obtained. A point to point curve can also be plotted so that the concentration of the unknown samples can be determined manually. If any dilutions are made should be adjusted before plotting.

 Standard curve can be plotted using semi-log, log/log, log/logit and its derivatives – the 4 or 5 parameter logistic models. Using software based/automated solutions makes it possible to consider more sophisticated graphing approaches. Using linear regression within a software package it is possible to check the R2 value to determine overall goodness of fit. For that portion of the curve where the relationship of concentration to readout has a linear relationship, R2 values >0.99 represent a very good fit. One aspect of the linear plot is that it compresses the data points on the lower concentrations of the standard curve, hence making that the most accurate range (area most likely to achieve the required R2 value). To counteract this compression a semi-log chart can be used; here the log of the concentration value (on x-axis) is plotted against the readout (on y-axis). This method gives an S-shaped data curve that distributes more of the data points into the more user friendly sigmoidal pattern.

 The log/log (log of concentration against log of readout) plot type manages to linearize more of the data curve. The low to medium standard concentration range is generally linear in this model, only the higher end of the range tends to slope off. The log/logit and its derivatives, the 4 or 5 parameter logistic models, are more sophisticated requiring more complex calculations and estimations of max, min, EC50, and slope values. The 5 parameter model additionally requires the asymmetry value. While these calibration curve models can deliver improved performance, a good starting point would be using the log-log plot.

 ELISA optimization

 Immobilization of antigen

 In solid phase coating antigen or antibody are attached to surface easily by passive adsorption (commonly called coating) which is a key feature of ELISA. Hydrohobic interactions between nonpolar protein structure and plastic matrix are the ones which make the proteins adsorb to the ELISA plate wells. These interactions are not dependent on net charge of the protein thus each protein has a different binding constant. The hydrophobicity of plastic/protein interactions can be exploited to increase binding since most of proteins hydrophilic residues are outside and hydrophobic are oriented towards inside. Partial denaturation of some proteins results in exposure of hydrophobic regions and ensures firmer interaction with the plastic. This can be achieved by exposing proteins to low pH or mild detergent and then dialysing against coating buffer before coating. The rate and extent of coating depends on these factors –

 Diffusion coefficient of attaching molecule

  1. Ratio of surface area being coated to volume of coating solution
  2. Concentration of the substance being adsorbed
  3. Temperature
  4. Time of adsorption

 Consistency between wells

 Consistency of results in any assay is an important aspect for which experimental conditions need to be standardized. Maintaining consistency helps to achieve reproducibility and accuracy. During an assay development it is imperative to test a range of parameters, in order to find the best suited experimental conditions. Capture and detection antibodies dilutions needs to be optimized in systematic manner. In addition, buffers, temperature, and humidity must be kept constant between and within experiments in order to produce standardized results.

 There are few requirements such as multiwell plates, multichannel pipets, and plate washers for a typical ELISA where sample size is high. These accessories help to provide consistent and faster results, as well as higher throughput. A very important checkpoint is to ensure the pipettes used are calibrated properly and on regular basis as it helps to prevent significant variation in the results. While working with multichannel pipettes few points should always be checked .Observe the level of the liquid in the pipet tip and the wells while performing the experiment to make sure no sample is far out of line with the others. As in multi-channel pipets sometimes the tips in the end rows do not always attach fully to the pipettor. So, these must be kept in mind otherwise reproducibility of the experiment will get affected.

Binding capacity

Plastic surfaces have a finite capacity for adsorption. The exact nature of protein influences its capacity to attach to microplate wells. A saturation level of 50 to 500 ng per well have been found valid for a variety of proteins when added as 50 ul volumes. By increasing volume of attaching protein the effective weight of protein per well can be increased which increases the surface area of the plastic in contact with the coating antigen.

Nonspecific binding

The adsorption process is nonspecific whereas antigen antibody interaction is very specific. Hence, any substance may absorb to the plastic matrix at any stage of ELISA assay. This must be kept in mind while assay designing because reagents may react with such substances. Nonspecific binding can be alleviated to a great extent through choosing systems which rely on direct adsorption of antigen such as sandwich technique in which specific ab capture and concentrate specific antigen.

Plasma and serum are complex samples containing several components. Matrix effects occur most often in plasma and serum samples where a series of components can cause interference. The cross-reactive substances in plasma or serum can lead to non-specific interactions in the matrix. Also the breakdown products that develop during the sample handling process can lead to nonspecific interactions. Matrix effect can be reduced by dilution of the sample; this should be verified by analyte recovery from spiked samples. Specialized buffers for sample dilution, coating, blocking and washing can ameliorate matrix effects and provide constant performance.

Suitability and concentration of antibodies

The initial task for optimization of ELISA protocol is to determine working concentrations for the antibodies. Prepare capture antibody dilutions in coating buffer at 0.5, 1, 2 and 5 μg/ml, then follow standard procedure. At the stage where sample addition would occur, add a high and low concentration of analyte that reflects the expected working range. For the detection antibody dilutions at 1:200, 1:1,000, 1:5,000 and 1:25,000 in buffer should be tried. Including a high and low concentration of the analyte helps to determine the dynamic range. The low concentration analyte indicates the sensitivity of the assay. If the blank sample shows excessive reading, above 0.2 absorbance units, these key components need to be checked for optimization: ELISA plate type and the blocking and washing buffers. If the background readings are appropriate but the sensitivity is not high enough further experimentation with matrix conditions, buffers, and incubation timings should be carried out. However, if no improvement is possible different antibody combinations need to be generated.

ELISA reader

An ELISA reader measures and quantitates the color differences in the wells of the ELISA plate. ELISA readers also known as micro plate readers do spectrophotometry; they emit light at one wave length, and measure the amount of light absorbed and reflected by an object such as a protein. A spectrophotometer measures ultraviolet and visible light. ELISA plate readers can also measure fluorescence and luminescence. Chemical dyes fluoresce or emit one color or wavelength when exposed to light. The amount of reflection, absorption and the color identify, and measure the amount of a substance.

ELISA reader has an edge over spectrophotometer as they require more sample per measurement. To use a spectrophotometer or ELISA plate reader, the molecule must be dissolved in solution. A spectrophotometer requires between 400 micro-liters to four milliliters, depending on the manufacturer and model. An ELISA plate reader needs about two to 100 microliters. ELISA plate readers measure more samples in a shorter period of time. A spectrophotometer measures one to six samples at a time. Typically, an ELISA plate measures 96 wells in an equivalent amount of time.

Review Article (1)

The research article deals with purified allergen specific immunotherapy (IT). The study investigates the efficacy of purified cockroach allergen immunotherapy with proteolytically active and inactive Per a 10 in allergic mouse model.. They carried out the study on Balb/c mice which were sensitized intraperitoneally with cockroach extract (CE) and purified allergen Per a 10 in separate groups. Mice were treated subcutaneously with phosphate-buffered saline (PBS), CE, active and inactive Per a 10 and challenged intranasally. Antigen specific IgE, IgG1 and IgG2a in serum and cytokines IL-4, IL-13, IFNγ, IL-10, TGF-β in bronchoalveolar lavage (BAL) fluid and spleen culture supernatant (CS) were estimated by enzyme-linked immunosorbent assay.

They determined specific immunoglobulin IgE, IgG1, and IgG2a levels in serum of different experimental groups by ELISA. Briefly, microtiter plates (Maxisorp; NuncTM Immunomodule, Roskilde, Denmark) were coated with 10 µg/ml of CE or 1 µg/ml of active Per a 10 in 0.1 M carbonate buffer (pH=9.6). Nonspecific sites were blocked with 3% defatted milk, washed, and incubated individually with mice sera for IgE (1:10), IgG1 (1:50), and IgG2a (1:50) estimation. After washing, the plates were incubated for 3 h with anti-mouse IgG1-peroxidase and anti-mouse IgG2a-peroxidase (1:1,000 PBS; BD Pharmingen, San Diego, CA, USA). For IgE estimation, the plate was incubated with biotinylated anti-mouse IgE (0.5 mg/ ml, BD Pharmingen, 1:1,000) at 25°C for 90 min. Following washing, it was incubated with streptavidin– peroxidase (1:1,000; BD Pharmingen) for 30 min. Color was developed using o-phenylene di-amine hydrochloride (Sigma, USA), and the absorbance was read at 492 nm. Similar to antibody detection they utilized ELISA for determining cytokines levels in BAL fluid and splenocyte culture supernatant. IL-4 (detection limit; 7.8 pg/ml), IL-13 (detection limit; 62.5 pg/ml), IFN-γ (detection limit; 31.3 pg/ ml), IL-10 (detection limit; 31.3 pg/ml), and TGF-β (detection limit; 62.5 pg/ml) levels were determined in undiluted BAL fluid and culture supernatants by ELISA using paired antibodies according to manufacturer’s instruction (BD Pharmingen, USA and R & D systems Inc. Minneapolis, MN, USA for IL-13). Briefly precoated ELISA plates were utilized for cytokine detection, wherein antibodies to cytokines to be investigated were coated in the wells from the vendor. Also standards were provided for the quantification of the cytokines level, along with the detection antibody.

They showed that cockroach-specific immunoglobulin levels in serum mice sensitized with CE (0.325±0.071; P<0.01) and Per a 10 (0.356±0.075; P<0.01) showed significantly increased levels of specific IgE after sensitization in serum than normal PBS control (0.122±0.043). After completion of protocol, CE-treated mice showed non-significant reduction in specific IgE levels compared to PBS-treated mice (P> 0.01). Further, immunotherapy with Per a 10 (proteolytically active and inactive) reduced IgE levels effectively compared to PBS-treated mice (P<0.01). There was no significant difference in IgE levels between active Per a 10and CE-treated mice (P>0.01). The enzymatically inactive Per a 10 showed significant reduction in specific IgE levels compared to active Per a 10- and CE-treated mice (P<0.01). Immunotherapy with Per a 10 (proteolytically active and inactive) in Per a 10-sensitized mice also showed significant reduction in specific IgE levels in comparison to PBS treated mice (P<0.01). Most importantly, IT with inactive Per a 10 showed significant reduction in specific IgE level compared to active Per a 10-treated mice in Per a 10-sensitized mice (P<0.01). Furthermore, IgE levels reduced significantly with active Per a 10 treatment in Per a 10-sensitized mice compared to CE-sensitized mice (#P< 0.01), whereas inactive Per a 10-treated mice showed remarkably significant reduction in IgE levels in active Per a 10-sensitized mice compared to CE-sensitized mice (P<0.001). IgG1 and IgG2a levels, however, did not change significantly in all the groups post-IT.

Cytokines in Bronchoalveolar Lavage Fluid and Splenocyte Culture Supernatant In CE-sensitized mice, IT with CE showed substantial reduction in IL-4 levels compared to PBS-treated mice (P>0.01). Per a 10 (proteolytically active and inactive) IT showed significant reduction in IL-4 levels than PBS-treated mice (P<0.01). The active Per a 10-treated mice, however, did not show significant reduction in IL-4 levels compared to CE-treated mice (P>0.01). But, IL-4 levels showed significant reduction in mice treated with proteolytically inactive Per a 10 compared to active Per a 10- and CE-treated group (P<0.01). Further, the IL-10 levels showed substantial increase in BAL fluid and culture supernatant post-IT with CE compared to PBS-treated mice (P>0.01). Immunotherapy with Per a 10 (proteolytically active and inactive) showed significant increase in IL-10 levels compared to PBS-treated mice (P<0.01). However, Per a 10-treated mice did not show significant increase in IL-10 levels compared to CE-treated group (P>0.01), and inactive Per a 10 showed maximum increase in IL-10 levels post-IT followed by active Per a 10- and CE-treated mice (P<0.01) in CE-sensitized mice. Immunotherapy with Per a 10 (proteolytically active and inactive) in Per a 10-sensitized mice showed significant reduction in IL-4 levels compared to PBS-treated mice (P< 0.01). IL-10 levels showed significant increase in BAL fluid and culture supernatant post-IT with Per a 10 (proteolytically active and inactive) compared to PBS treated mice (P<0.01). Most importantly, IT with inactive Per a 10 showed significant reduction in IL-4 level accompanied by maximum increase in IL-10 level compared to active Per a 10-treated mice (P<0.001). IFN-γ, IL-13, and TGF-β levels, however, did not change significantly post-IT in all the groups. Additionally, IL-10 levels showed significant increase with active Per a 10 treatment.

Review Article (2)

In another study by same group utilized ELISA to formulate preservatives to enhance shelf life of protease rich periplaneta americana allergen extract during different storage conditions. Allergenic proteins in extracts degrade rapidly and lose potency on storage. Hence, formulation of optimum conditions is required to enhance shelf life of extracts for proper allergy diagnosis and immunotherapy. In the study, allergenic potency of P. americana proteins was evaluated after storage with ε-aminocaproic acid (EACA), sucrose, glycerol, pepstatin A, and aprotinin, individually for 1, 3, 6, and 12 months at 4, 25, and 37◦C. P. americana extract stored with EACA and sucrose individually retained potency comparable to proteins in standard extract (freeze-dried extract, stored at−70◦C) upto 6 months at 4◦C. The extracts without preservatives or with glycerol, pepstatin A, aprotinin, or stored at 37/25◦C were severely degraded and lost potency by 3 months. A formulation containing a combination of EACA and sucrose enhanced the shelf life of P. americana proteins upto 12 months at 4◦C. Hence, EACA and sucrose together show better potential for stabilization of protease-rich extracts.

            ELISA was carried out with P. americana extracts, wherein microtiter plate was coated with cockroach protein (1 µg/100 µL/well) in carbonate buffer, pH 9.6 and incubated overnight at 4◦C. The free sites were blocked with 3% defatted milk in PBS for 3 h at 37◦C and incubated with a pool of 20 cockroach-positive patients’ sera (1:10 v/v) at 4◦C overnight. After washing with PBST (PBS containing 0.2% Tween 20), the plate was incubated for 3 h at 37◦C with antihuman-IgE peroxidase (Sigma) (1:1000) and color developed with o-phenylene diamine. The reaction was stopped by adding 5N H2SO4 and read at 492 nm in an ELISA reader. ELISA was performed in triplicates and the average of three readings was taken for analysis.

Also they performed ELISA inhibition assay where specific IgE inhibition was carried out to determine the potency of the various treated extracts. Microtiter plate was coated with standard P. americana extract (1 µg/100 µL/well) and blocked with 3% defatted milk in PBS. The plate was incubated with a preincubated mixture of 1:10v/v diluted cockroach hypersensitive pooled patients’ sera and graded amounts of P. americana extracts (0.1, 1, 10, 100, 1000 ng) as inhibitor in a 100 µL volume. The remaining steps were the same as followed for ELISA.

Extracts stored individually with EACA or sucrose for 6 months and EACA + sucrose for 12 months could diagnose all the cockroach-hypersensitive patients tested. Although the extract stored at 4◦C for 12 months with a combination of preservative showed mild degradation and a drop in relative potency, its specific IgE binding capacity and skin test reactivity was similar to standard extract as it was able to elicit marked positive skin reactivity in all the cockroach-hypersensitive patients. They stated that the potency of the extracts should be assessed based on a combination of both in vitro and in vivo parameters. The extracts stored with EACA or sucrose individually for 12 months could detect sensitization in only 25% (6/24) and 17% (4/24) cases, respectively. However, extract without preservative identified allergy in just 4% (1/24) of the cockroach-allergic cases (p>0.05). It shows that cockroach extracts without preservative or stored individually with EACA/sucrose for 12 months missed many of the cockroach-hypersensitive patients. This is also substantiated by 25 times more potency of the extract stored with formulation (RP 0.5) as compared to extract without preservative (RP 0.02). In conclusion, EACA and sucrose stabilized P. americana extract individually for 6 months whereas the formulation containing both increases the shelf life upto 1 year and can be used safely for stabilization and storage of protease-rich allergen extracts for diagnosis and therapy.

Review on Performance in screening HIV: Rapid Test vs ELISA

Approximately 36 million people are infected with human immunodeficiency virus across the world. In resource-limited settings, there seems to be a migration from ELISA to rapid tests for screening of human immunodeficiency virus. This article is focused on presenting facts that compare ELISA and rapid tests to produce a winner in terms of accuracy.

It is understood there tend to be inconsistencies when two different techniques are compared. Therefore, Western Blot, as most researchers would agree, is the most efficient of all HIV testing techniques, was brought into the experiment to confirm results and compare the performance of ELISA and rapid testing.

In testing HIV, two testing algorithms are used – parallel and serial. In parallel testing strategy, the samples are tested using two different tests i.e. rapid and ELISA. In serial testing strategy, the result of one test determines the need for another. In healthcare centers where serial testing strategy is used, the need for accuracy is paramount so as not to miss infection through false negatives and create confusion through false positives. The screening test is expected to be highly sensitive and the subsequent test is expected to be highly specific to weed out false positives and false negatives.

For this study, 787 samples were tested using both rapid testing kits and ELISA. When samples were analysed by rapid testing kits, 36 samples were found to be reactive, and 40 samples were found to be reactive as per ELISA.

When all the positive samples were processed through confirmatory test, Western Blotting, all the reactive samples obtained through ELISA were found to be reactive as well. Therefore, it is understood, four reactive samples were misdiagnosed as “HIV negative” when tested via rapid testing kits.

When all the reactive samples obtained via rapid tests were processed through the confirmatory test, western blotting, 5 samples were found to be nonreactive. Therefore, in addition to missing four reactive samples and rapid tests misdiagnosed 5 nonreactive samples as reactive.

Implications resulting from false positives and false negatives are huge as it leads to not only confusion but also poor understanding on the part of the patients receiving a reactive report. The false positives of rapid testing kits are often attributed to technical errors, mislabeling of samples, problems with components of the test devices and cross reactivity. In this experiment, both ELISA and Rapid kits were handled by technicians with the expertise to ensure handling accuracy.

Despite high sensitivity, the longer turnaround time of ELISA seems to be the problem for people undergoing HIV testing, whereas rapid tests provide an excellent option for testing immediately. The possibility of missing early infections (false negatives) is a matter of huge concern as the general population is exposed to unwarranted risks.

Following serial testing algorithm across all healthcare centers could be of greater use as preliminary report could be provided immediately (results of Rapid tests) followed by testing of all samples by ELISA to identify any false negative and false positive results. The problems posed by rapid tests can be overcome using ELISA test and western blotting as confirmatory tests. In addition, detection of p24 antigen via rapid tests would significantly enhance efficiency.

 

Protocols

Direct ELISA

  1. The antigen is diluted to a final concentration of 20 μg/ml in PBS. The wells of a PVC microtiter plate are coated with the antigen of 50 μl in the top wells of the plate.
  2. The plate is covered with adhesive plastic and incubated for 2 hours at room temperature.
  3. The coating solution is discarded and completely removed by flicking the plate over a sink and the remaining drops are removed by patting the plate on a paper towel.
  4. The remaining protein-binding sites in the coated wells are blocked by adding 200 μl blocking buffer.
  5. The plate is covered with an adhesive plastic and incubated for at least 2 hours at room temperature.
  6. The plate is washed twice with PBS.
  7. 100 μl of the antibody is added to the blocking buffer before use.
  8. The plate is covered with an adhesive plastic and incubated for 2 hours.
  9. The plate is washed four times with PBS.
  10. the substrate solution is dispensed in each well.
  11. Post color development, stop solution is added to the wells.
  12. Absorbance of each well is studied against a plate reader.

Indirect ELISA

  1. The antigen is diluted to a concentration of 20 µg/ml in PBS. The wells of a PVC microtiter plate are coated with the antigen by pipetting 50 µl of the antigen dilution in the top wells of the plate.
  2. 200 µl blocking buffer is added to block the remaining protein-binding sites in the coated wells with 5% non-fat dry milk.
  3. The plate is covered with adhesive plastic and incubated for at least 2 hr at room temperature.
  4. The plate is washed twice with PBS.
  5. 100 µl of diluted primary antibody is added to each well.
  6. The plate is covered with an adhesive plastic and incubated for 2 hours at room temperature.
  7. The plates should be washed with PBS four times
  8. 100 µl of conjugated secondary antibody diluted at optimal concentration in blocking buffer is added.
  9. The plate is covered with adhesive plastic and incubated for 1 – 2 hours at room temperature.
  10. Again, the plates are washed with PBS four times.

Sandwich ELISA

  1. The wells of the microtiter plates are coated with the capture antibody at 1–10 μg/mL concentration in carbonate/bicarbonate buffer. In case unpurified antibodies are used, the concentration of the protein sample should be 10 μg/mL) to compensate for the lower concentration of specific antibody.
  2. The plate is covered with adhesive plastic and incubated at 4°C for 12 hours.
  3. The coating solution is discarded and the plate is washed twice by 200 μL PBS. The PBS is also removed completely by flicking the plate over a sink and the by patting the plate on a paper towel.
  4. The remaining protein binding sites in the wells are blocked by 200 μL blocking buffer (5% non-fat dry milk/PBS) per well.
  5. The plate is covered with the adhesive plastic and incubate for at least 2 hours at room temperature or overnight at 4°C.
  6. The plate is washed twice with 200 µL PBS.
  7. The diluted samples of 100 μL is added to each well. The signals exhibited are compared with a standard curve. Both standards and blank with each plate are incubated for 90 minutes at room temperature.
  8. The concentration range is optimized to obtain a standard curve. This ensures the standards spans the detection range of antibody binding.
  9. the samples are removed and the plate is washed twice with 200 μL PBS.
  10. 100 μL of diluted detection antibody is added to each well. It is important to ensure detection antibody recognizes a different epitope on the target protein to the capture antibody to prevent interference with antibody binding.
  11. The plate should be covered with adhesive plastic and incubated for 2 hours at room temperature.
  12. The plates are washed with PBS four times and 100 μL of conjugated secondary antibody diluted in blocking buffer is added.
  13. The plate is covered with adhesive plastic and incubated for an hour at room temperature.
  14. The plate is washed four times with PBS.
  15. Detection involves enzymes such as Horse radish peroxidase (HRP) and alkaline phosphatase (ALP). Blocking treatment with levamisole or 0.3% H2O2 in methanol. This helps in hindering nonspecific signal.

Competitive ELISA

The assay is the most precise of

  1. Unlabeled antibody is incubated with the sample antigen.
  2. The incubated complex is added to the 96-well plates coated with the same antigen in the complex
  3. The unbound antibody is washed away from the plate.
  4. More antigens in the sample leads to lesser antibodies binding to the antigens in the well, hence the procedure is termed competitive.
  5. Secondary antibody conjugated with the enzyme is added to the well.
  6. A suitable substrate is added and enzymes elicit a chromogenic or fluorescent response.

Compare and Contrast: Indirect ELISA vs. Sandwich ELISA

Indirect ELISA

The assay is usually carried out in two stages. Like Direct ELISA, the antigen is coated to a polystyrene multiwell plate. In the first stage, unlabeled primary antibody is introduced into the well which is specific to an antigen. In the second stage, enzyme labeled secondary antibody (often polyclonal antibody) is introduced to the well.

The advantages of Indirect ELISA include enhanced sensitivities since more than one labeled antibodies are used for bounding with primary antibody. The experimental procedure can be made flexible as per the demands of the study given the stages in Indirect ELISA.

 

Sandwich ELISA

The assay is highly efficient in sample antigen detection and quantification. The assay is suitable for antigens that contain at least two antigenic epitopes capable of binding to antibody. Both monoclonal and polyclonal antibodies are widely used as capturing and detection antibodies in Sandwich ELISA systems. The quantification of antigens happens between two layers of antibodies and therefore the method is termed as sandwich ELISA.

The assay is more sensitive and specific than direct or Indirect ELISA i.e. up to 2 to 5 times. The difficulty in sandwich ELISA lies in optimization and selecting tested pair antibodies. This ensures antibodies chosen are detecting different epitopes on the target protein without interfering with other antibody binding. As a high precision assay, the sample need not be purified before analysis.

 

Quora Submissions: ELISA

Can someone simplify Enzyme Linked Immunosorbent Assay (EIA)?

Enzyme-linked Immunosorbent Assay (shortened as ELISA) is used to identify peptides, proteins, antibodies and hormones. Also, called as enzyme immunoassay (EIA), ELISA finds use in the fields of biotechnology and medicine as a diagnostic tool. Mainly, antibodies and color changes are used to identify target substances. Also, ELISAs are useful in measuring antigen and antibody concentration.

Before the advent of ELISA, radioimmunoassay employing radioactively-labelled antigens and antibodies were used. Radioactivity served as the reporter signal indicating specific antigen or antibody. As radioimmunoassay posed significant health risks to researchers, alternatives were sought.

In 1960s, Enzyme linking process was developed by two different teams spearheaded by Stratis Avrameas and G. B. Pierce. In the same period, immunosorbent preparation technique was published by Wide and Jerker Porath. Independent research papers published in 1971 by Peter Perlmann and Eva Engvall at Stockholm University in Sweden, and Anton Schuurs and Bauke van Weemen in the Netherlands produced the knowledge that go into making ELISA.

The conventional ELISA involves usage of chromogenic reporters and substrates to produce color changes to indicate the presence of specific antigen or an analyte. Newer Assay techniques make use of fluorogenic, electrochemiluminescent, and quantitative PCR reporters to create quantifiable signals. The advantage of using advanced reporters help in measuring multiple analytes in a single or cycle of assays (Multiplexing) and higher sensitivities (specificity and sensitivity)

Technically, newer assays use reporters that are not enzymes in most cases, nonetheless the underlying principles of the assays are similar. Therefore, these assays are grouped as ELISAs.

ELISA works by coupling antibody or antigen to assay enzyme. The assay combines the specificity of antibody and sensitivity of assay enzymes to primarily detect antigens through assay antibody or antibodies through assay antigens. The sensitivity and precision of the assay is enhanced by coating the plate with high-affinity antibodies.

To know more about ELISA Types, advantages and disadvantages and methods, refer ELISA page in Mybiosource Learning Center.

What are the advantages and limitations of using Western-blot vs. ELISA vs. flow cytometry?

First, let us discuss the definition of Western blotting, ELISA and Flow cytometry in simple language. You can always follow the link to get more detailed information on these assays/methods.

ELISA or Enzyme-linked Immunosorbent Assay is useful in identifying a substance using antibodies and color changes.

Western blotting is used to separate and identify proteins. Through gel electrophoresis, the proteins are separated based on molecular weight. Find protocol and detailed explanation on western blotting in mybiosource learning Center.

Flow cytometry is useful in analyzing physical and chemical properties of particles. In biological research, cell components are fluorescently labelled and then excited by a laser beam to emit light at different wavelengths. Relative granularity, size, fluorescence intensity and internal complexity is mainly studied via flow cytometry. Find protocol and detailed explanation on flow cytometry in mybiosource learning Center.

How are antibodies detected?

 Initially, identification and characterization of antibodies were limited to the field of scientific research. As the measurement and identification of bacterial infections, viral infections, autoimmune diseases and allergies became more and more important in clinical settings, methods of detecting antibodies have evolved big time and newer/efficient methods are being offered.

Two important methods for detection of antibodies actively used are immunoprecipitation assay and immunoblotting. While there are assays that are superior to immunoblotting, the cost factor (specific to clinical settings) plays a role in making those assays economically not viable.

Immunoprecipitation

To analyze a protein, you must have a reliable detection system that unambiguously enables you to follow the target protein. This is especially true when the target molecule is in crude or even semipurified form. The purification of a bioactive molecule is frequently accomplished by using a definitive assay designed to recognize a property of the target protein. You can read and find protocol of Immunoprecipitation in mybiosource learning center.

Immunoblotting

The techniques use antibodies to identify target proteins from sample protein species. It involves identification of target protein via antigen-antibody specificity.  Proteins are separated by electrophoresis and transferred onto membranes. The membrane is overlaid with a specific target (primary antibody) and a secondary labeled antibody i.e. enzymes or radioisotopes. You can read and find protocol of Immunoblotting in mybiosource learning center.

How do direct and indirect ELISA differ?

Direct ELISA: Quicker of all the ELISA, the direct assay is used in detection of antigens coated to the multiwell plate by an antibody conjugated to an enzyme. The assay is less consuming in terms of time, steps and reagents.

Indirect ELISA: The assay is usually carried out in two stages. Like Direct ELISA, the antigen is coated to a polystyrene multiwell plate. In the first stage, unlabeled primary antibody is introduced into the well which is specific to an antigen. In the second stage, enzyme labeled secondary antibody (often polyclonal antibody) is introduced to the well.

The advantages of Indirect ELISA include enhanced sensitivities since more than one labeled antibodies are used for bounding with primary antibody. The experimental procedure can be made flexible as per the demands of the study given the stages in Indirect ELISA.

Advantages and Limitations of ELISA, Western Blotting and Flow Cytometry

  1. The sensitivity and specificity of ELISA is 98%.
  2. The sensitivity and specificity of Western blot/Flow cytometry is 100%.
  3. Running ELISA is cheaper compared with western blot and Flow Cytometry.
  4. Western blot is time consuming due to lengthy and tedious procedures i.e. 6-16 hours.
  5. Significant amount of time is spent on processing the western blot for detection.
  6. Quality of antibody/antigen is important to both ELISA and Western blotting.
  7. ELISA Kits are readily available for well-known target proteins/substances.
  8. Factors affecting western blot results include transfer method, type of membrane used, blocking buffer, reagents and probing techniques.
  9. Flow cytometry requires management by a highly trained specialist and continuous maintenance by service engineers as complex instruments are prone to microfluidics system blockages in addition to cleaning and laser calibration.
  10. Advantages of flow cytometry include high speed analysis depending on the flow rate, measures both single and large number of cells, measures multiple parameters, quantifies fluorescence intensities, sorts predefined population of cells, in addition to identifying small populations.

How do PCR and ELISA differ in their disease diagnostic abilities?

From HIV detection point of view, the approved window period for ELISA test is 90 days or 3 months i.e. the maximum amount of time taken for human body to produce antibodies.

The PCR test can be used for HIV diagnosis even within 72 hours. Polymerase chain reaction (PCR) tests are used to detect HIV’s genetic material, called RNA. The test is not widely used as it is expensive compared to both western blot and ELISA.

ELISA and Western blot are known for sensitivity and specificity for antibodies/antigens. On the other hand, Polymerase Chain Reaction (PCR) is used to amplify DNA and RNA through reverse transcription.

The Polymerase chain reaction (PCR), one of the most powerful technologies in molecular biology, helps in amplifying or copying specific sequence of DNA or complementary template employing oligonucleotides, heat-stable DNA polymerase and thermal cycling. With each cycle, the number of target molecules is doubled theoretically, and DNA is exponentially amplified. Find protocol and detailed explanation on PCR in mybiosource learning Center.

ELISA, in contrast, used to identify peptides, proteins, antibodies and hormones. Also, called as enzyme immunoassay (EIA), ELISA finds use in the fields of biotechnology and medicine as a diagnostic tool. Mainly, antibodies and colour changes are used to identify target substances. Also, ELISAs are useful in measuring antigen and antibody concentration.

How do direct and indirect ELISA differ?

Direct ELISA: Quicker of all the ELISA, the direct assay is used in detection of antigens coated to the multiwell plate by an antibody conjugated to an enzyme. The assay is less consuming in terms of time, steps and reagents.

Indirect ELISA: The assay is usually carried out in two stages. Like Direct ELISA, the antigen is coated to a polystyrene multiwell plate. In the first stage, unlabeled primary antibody is introduced into the well which is specific to an antigen. In the second stage, enzyme labeled secondary antibody (often polyclonal antibody) is introduced to the well.

The advantages of Indirect ELISA include enhanced sensitivities since more than one labeled antibodies are used for bounding with primary antibody. The experimental procedure can be made flexible as per the demands of the study given the stages in Indirect ELISA.

What is best between sandwich elisa and competitive elisa as their advantages are almost same?

It is basically horse for the courses logic!

Sandwich ELISA is mainly meant for detecting antigens with two antigenic epitopes capable of binding to antibody.

Both monoclonal and polyclonal antibodies are widely used as capturing and detection antibodies in Sandwich ELISA systems. The quantification of antigens happens between two layers of antibodies and therefore the method is termed as sandwich ELISA.

The assay is more sensitive and specific than direct or Indirect ELISA i.e. up to 2 to 5 times. The difficulty in sandwich ELISA lies in optimization and selecting tested pair antibodies. This ensures antibodies chosen are detecting different epitopes on the target protein without interfering with other antibody binding. As a high precision assay, the sample need not be purified before analysis.

The competitive/inhibition ELISA is predominantly used to measure the concentration of an antigen or antibody in a sample by detecting interference in an expected signal output.

Conclusion: Sandwich ELISA for detection vs. Competitive ELISA for measuring concentration.

 

Frequently Asked Questions

What is a primary antibody?

Primary antibodies are antibodies used in detection of biomarkers for diseases such as cancer, diabetes, Parkinson’s and Alzheimer’s disease. Primary antibodies bind to target proteins, antibodies or antigens.

What is a secondary antibody?

Antibody that attaches to the primary antibody to detect target antigen is referred as secondary antibody. Secondary antibody have specificity for isotype of primary antibody and often is conjugated. Technically, the secondary antibody’s FAB domain binds to primary antibody’s Fc domain.

Secondary antibodies find application in ELISA, western blot, Immunostaining, Immunohistochemistry and Immunocytochemistry studies.

What is an antibody conjugate?

Conjugated antibody is a monoclonal or polyclonal antibody linked to probe enzyme or agents. It helps in detection in wide range of assay techniques. Also, conjugated antibodies help in detection, purification and microscopy application.

What is the difference between western blot and ELISA?

Both the tests measure immune system’s response to infectious agents. But, ELISA is less sophisticated and cost effective compared with Immunoblotting. The advantage of the Western Blot over the ELISA test is that far more indicators are examined than the single antigen in ELISA.

 What is a western blot?

Western blot is also a detection assay. Unlike ELISA, viral proteins are separated, immobilized and visualized. The proteins are collected into a gel slab and electric current is passed through them. Different proteins based on their size move at different velocities. Once these proteins are segregated by size, the procedure continue like ELISA.

What is ELISA test used for?

ELISA is used quantifying antibody/antigen concentration in viral tests, and as a consumer product ELISA finds application in home pregnancy tests. It is also used in detecting potential food allergens in food products such as milk, peanuts, almonds and eggs. ELISA is used widely in the fields of Immunology, Toxicology and Diagnostics.

Is ELISA test reliable?

As a biochemical assay, ELISA is reliable and effective in detecting antibodies/antigens. In some medical cases, the positive or negative results are always confirmed by Western Blotting. This is mainly done to confirm the test results.

What is the Difference between Direct and Indirect ELISA?

In direct ELISA, the method of antigen mobilization is not specific. When serum is used as the source of target antigen, the proteins in the sample may stick to microtiter plate well and analyte in serum must compete with other proteins to bind with the well surface. This problem is eliminated by using secondary antibody specific for the test antigen in Indirect or sandwich ELISA. This is the key difference between direct and Indirect ELISA.

What is the Difference between Sandwich ELISA and Competitive ELISA?

Competitive ELISA is known for precision and reproducibility whereas Sandwich ELISA is known for sensitivity and specificity. The competitive ELISA is more attractive if no antibody pair can be identified for sandwich ELISA, and when Analyte is too small to bind with a primary and secondary antibody.

What are the variants of Sandwich ELISA?

Sandwich ELISA is known for specificity and sensitivity, but the inherent disadvantage lies in finding antibody pairs to carry out the assay. If the detection antibody is conjugated with an enzyme, the assay is called direct sandwich ELISA and if the secondary antibody is unlabelled, the need for an antibody enzyme conjugate arises, these assays are called Indirect Sandwich ELISA.

What is the difference between Indirect and Sandwich ELISA?

The most popular od ELISAs, Indirect ELISA uses a secondary antibody that binds with primary antibody for detection. The secondary antibody has specificity for primary antibody.

The most powerful in terms of specificity and sensitivity, Sandwich ELISA captures the analyte between two primary antibodies – the capture and detection antibody.

Why is PBS used in ELISA?

Phosphate Buffered Saline is a liquid formulation of buffers and saline. It is used in ELISA procedure to balance PH without disrupting protein binding sites.

What are the commonly used substrates for ELISA?

Horseradish peroxide, Alkaline Phosphatase, β-Galactosidase and Urease. Substrates allow direct visualization and enable kinetic studies.

What is a chromogenic reporter?

Substrates that allow direct visualization and enable kinetic studies are chromogenic reporters. They are far less sensitive compared with fluorescent or chemiluminescent substrates. The detection is assisted with standard absorbance plate readers common to many laboratories. The ease with which one can use chromogenic reporters make them a popular choice as reporting agents.

What are the factors that could affect signal generation in ELISA?

Shape and material of the plate, pH of the buffer, specificity of the capture antibody, incubation time and temperature, conformation and stability of target antigen, specificity, affinity and cross reactivity of detection antibody, concentration and cross reactivity of enzyme conjugate, sensitivity and age of the substrate, and filters and exposure time of the imaging instrument.

Can non-purified antibody be used in ELISA?

Non-purified antibody can be used but may result in higher background. It is highly recommended that purified antibodies be used for optimal signal to noise ratio.

What are some commonly used coating and detection antibodies?

Polyclonal serum, crude ascites, affinity purified monoclonal and affinity purified polyclonal antibody.

What are the recommended secondary antibody concentrations for ELISA?

For Horseradish peroxide, the concentration for colorimetric system should be 20 – 200 ng/ml, the concentration for fluorescent system should be 25 – 50 ng/ml, 10-100 ng/ml for chemiluminescent system.

For Alkaline Phosphatase, 100 – 200 ng/ml for colorimetric system and 40 – 200 ng/ml for chemiluminescent system.

How long does it take to run ELISA?

The assay can be run in less than 3 hours in any formats.